• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Breakthrough bacteraemia due to tigecycline-resistant Escherichia coli with New Delhi metallo-β-lactamase (NDM)-1 successfully treated with colistin in a patient with calciphylaxis.

作者信息

Stone Neil R H, Woodford Neil, Livermore David M, Howard Julia, Pike Rachel, Mushtaq Shazad, Perry Claire, Hopkins Susan

出版信息

J Antimicrob Chemother. 2011 Nov;66(11):2677-8. doi: 10.1093/jac/dkr337. Epub 2011 Aug 16.

DOI:10.1093/jac/dkr337
PMID:21846669
Abstract
摘要

相似文献

1
Breakthrough bacteraemia due to tigecycline-resistant Escherichia coli with New Delhi metallo-β-lactamase (NDM)-1 successfully treated with colistin in a patient with calciphylaxis.在一名患有钙化防御的患者中，耐替加环素的产新德里金属β-内酰胺酶（NDM）-1大肠杆菌所致的突破性菌血症经黏菌素成功治疗。
J Antimicrob Chemother. 2011 Nov;66(11):2677-8. doi: 10.1093/jac/dkr337. Epub 2011 Aug 16.
2
Efficacies of colistin and tigecycline in mice with experimental pneumonia due to NDM-1-producing strains of Klebsiella pneumoniae and Escherichia coli.产 NDM-1 肺炎克雷伯菌和大肠埃希菌致实验性肺炎小鼠中多黏菌素和替加环素的疗效。
Int J Antimicrob Agents. 2012 Mar;39(3):251-4. doi: 10.1016/j.ijantimicag.2011.10.012. Epub 2011 Dec 7.
3
Use of tigecycline for the treatment of prolonged bacteremia due to a multiresistant VIM-1 and SHV-12 beta--lactamase-producing Klebsiella pneumoniae epidemic clone.使用替加环素治疗由产多耐药VIM-1和SHV-12β-内酰胺酶的肺炎克雷伯菌流行克隆引起的长时间菌血症。
Diagn Microbiol Infect Dis. 2008 Mar;60(3):319-22. doi: 10.1016/j.diagmicrobio.2007.09.017. Epub 2007 Nov 9.
4
In vivo emergence of tigecycline resistance in multidrug-resistant Klebsiella pneumoniae and Escherichia coli.多药耐药肺炎克雷伯菌和大肠埃希菌体内出现替加环素耐药。
Antimicrob Agents Chemother. 2012 Aug;56(8):4516-8. doi: 10.1128/AAC.00234-12. Epub 2012 May 29.
5
Carbapenem therapy for bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.产超广谱β-内酰胺酶大肠埃希菌或肺炎克雷伯菌菌血症的碳青霉烯类治疗。
Diagn Microbiol Infect Dis. 2011 May;70(1):150-3. doi: 10.1016/j.diagmicrobio.2010.12.008. Epub 2011 Mar 12.
6
Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy.通过改变抗菌药物使用政策控制儿童医院中产超广谱β-内酰胺酶的大肠埃希菌和肺炎克雷伯菌
J Antimicrob Chemother. 2007 Sep;60(3):629-37. doi: 10.1093/jac/dkm225. Epub 2007 Jun 27.
7
Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay.替加环素单独及联合黏菌素和美罗培南对产碳青霉烯酶肠杆菌科细菌（KPC）菌株的时间杀菌试验研究。
Int J Antimicrob Agents. 2011 Mar;37(3):244-7. doi: 10.1016/j.ijantimicag.2010.10.031. Epub 2011 Jan 13.
8
[Urinary tract infection by multiresistant Escherichia coli and Klebsiella pneumoniae: case report].[多重耐药大肠杆菌和肺炎克雷伯菌引起的尿路感染：病例报告]
Rev Esp Quimioter. 2012 Dec;25(4):295-6.
9
Successful treatment of NDM-1 Klebsiella pneumoniae bacteraemia in a neutropenic patient.成功治疗一名中性粒细胞减少患者的NDM-1肺炎克雷伯菌菌血症。
Scand J Infect Dis. 2012 Apr;44(4):312-4. doi: 10.3109/00365548.2011.633549. Epub 2011 Nov 29.
10
[Epidemiological study on extended-spectrum beta-lactamase-producing in clinical isolates and selection of antibacterial drugs in China ].[中国临床分离产超广谱β-内酰胺酶菌株的流行病学研究及抗菌药物选择]
Zhonghua Yi Xue Za Zhi. 2004 Nov 17;84(22):1918-20.

引用本文的文献

1
Clinical outcomes in elderly patients with infections caused by NDM-producing Klebsiella pneumoniae: results from a real-life retrospective single center study in an endemic area.产 NDM 肺炎克雷伯菌感染老年患者的临床转归：流行地区真实世界回顾性单中心研究结果。
Intern Emerg Med. 2023 Nov;18(8):2261-2269. doi: 10.1007/s11739-023-03416-3. Epub 2023 Sep 12.
2
Microbial Musings - November 2021.微生物随想——2021年11月
Microbiology (Reading). 2022 Jan;167(11). doi: 10.1099/mic.0.001134.
3
Extraintestinal Pathogenic : Virulence Factors and Antibiotic Resistance.
肠道外致病性：毒力因子与抗生素耐药性
Pathogens. 2021 Oct 20;10(11):1355. doi: 10.3390/pathogens10111355.
4
The Revival of Aztreonam in Combination with Avibactam against Metallo-β-Lactamase-Producing Gram-Negatives: A Systematic Review of In Vitro Studies and Clinical Cases.氨曲南与阿维巴坦联合用于治疗产金属β-内酰胺酶革兰阴性菌的研究进展：体外研究与临床病例的系统评价
Antibiotics (Basel). 2021 Aug 20;10(8):1012. doi: 10.3390/antibiotics10081012.
5
NDM-1-Positive at a Teaching Hospital in Southwestern China: Clinical Characteristics, Antimicrobial Resistance, Molecular Characterization, Biofilm Assay, and Virulence.中国西南部一家教学医院的耐碳青霉烯类肠杆菌科细菌（NDM-1）阳性菌株：临床特征、抗菌药物耐药性、分子特征、生物膜检测及毒力研究
Can J Infect Dis Med Microbiol. 2020 Oct 9;2020:9091360. doi: 10.1155/2020/9091360. eCollection 2020.
6
Breakthrough and persistent bacteremia due to serotype K1 in an immunocompetent patient.免疫功能正常患者中由K1血清型引起的突破性和持续性菌血症。
IDCases. 2020 Jun 27;21:e00893. doi: 10.1016/j.idcr.2020.e00893. eCollection 2020.
7
Clinical Features and Outcomes of Bloodstream Infections Caused by New Delhi Metallo-β-Lactamase-Producing During a Regional Outbreak.新德里金属β-内酰胺酶产生菌引起的血流感染在区域暴发期间的临床特征及转归
Open Forum Infect Dis. 2020 Jan 21;7(2):ofaa011. doi: 10.1093/ofid/ofaa011. eCollection 2020 Feb.
8
NDM Metallo-β-Lactamases and Their Bacterial Producers in Health Care Settings.在医疗环境中 NDM 型金属β-内酰胺酶及其细菌生产者
Clin Microbiol Rev. 2019 Jan 30;32(2). doi: 10.1128/CMR.00115-18. Print 2019 Mar 20.
9
Azidothymidine Produces Synergistic Activity in Combination with Colistin against Antibiotic-Resistant .叠氮胸苷与黏菌素联合使用对耐药 产生协同作用。
Antimicrob Agents Chemother. 2018 Dec 21;63(1). doi: 10.1128/AAC.01630-18. Print 2019 Jan.
10
Use of succinic & oxalic acid in reducing the dosage of colistin against New Delhi metallo-β-lactamase-1 bacteria.琥珀酸和草酸在降低多黏菌素针对新德里金属β-内酰胺酶-1 细菌的用量中的应用。
Indian J Med Res. 2018 Jan;147(1):97-101. doi: 10.4103/ijmr.IJMR_1407_16.